AVVAA World Health Care Products, Inc.
AVVH · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.29 | 0.00 | 0.00 |
| FCF Yield | -6.36% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -118.19 | 0.00 | 0.00 | -112.37 |
| Quality | ||||
| ROIC | -16.62% | 0.00% | 0.00% | -15.88% |
| Gross Margin | 32.71% | 0.00% | -388.15% | 0.00% |
| Cash Conversion Ratio | 6.29 | 0.30 | 0.32 | 0.38 |
| Growth | ||||
| Revenue 3-Year CAGR | 32.48% | – | -72.44% | -100.00% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -6.86 | 0.00 | 0.00 | 4.37 |
| Interest Coverage | -7.89 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,862.09 | 0.00 | 0.00 | 0.00 |